Compare MTEK & MODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MTEK | MODD |
|---|---|---|
| Founded | 2008 | 1998 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | | Industrial Specialties |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.7M | 11.2M |
| IPO Year | 2021 | 2019 |
| Metric | MTEK | MODD |
|---|---|---|
| Price | $1.05 | $2.53 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 51.6K | ★ 380.7K |
| Earning Date | 05-12-2026 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.94 | $0.12 |
| 52 Week High | $4.27 | $6.16 |
| Indicator | MTEK | MODD |
|---|---|---|
| Relative Strength Index (RSI) | 41.15 | 43.07 |
| Support Level | $0.97 | $0.29 |
| Resistance Level | $1.13 | $5.84 |
| Average True Range (ATR) | 0.07 | 0.46 |
| MACD | -0.01 | -0.07 |
| Stochastic Oscillator | 18.72 | 10.89 |
Maris Tech Ltd is a business-to-business approach, or B2B provider of remote video, audio, telemetry acquisition, distribution, and sharing solutions and products, using high-end digital video, audio, and wireless communication technologies. It designs, develops, manufactures and commercially sells miniature intelligent video and audio surveillance and communication systems, which are offered as products and solutions for the professional as well as the civilian and home security markets.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, marketing and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.